Señales en vivo de 206650.KQ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 02:30):

Stats
Volumen de hoy	346 253
Volumen promedio	566 356
Capitalización de mercado	494.00B
EPS	KRW-85.00 ( 2023-09-30 )
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	-114.13
ATR14	KRW15.93 (0.12%)

Volumen Correlación

Largo: 0.07 (neutral)

Corto: -0.64 (weak negative)

Signal:(62.79) Neutral

EuBiologics Co., Ltd. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

EuBiologics Co., Ltd. Correlación - Moneda/Commodity

0.67
( moderate )

0.58
( weak )

0.48
( neutral )

0.75
( moderate )

-0.31
( neutral )

0.83
( strong )

EuBiologics Co., Ltd. Finanzas

Annual	2023
Ingresos:	KRW69.37B
Beneficio Bruto:	KRW32.66B (47.08 %)
EPS:	KRW-380.79

FY	2023
Ingresos:	KRW69.37B
Beneficio Bruto:	KRW32.66B (47.08 %)
EPS:	KRW-380.79

FY	2022
Ingresos:	KRW55.47B
Beneficio Bruto:	KRW22.22B (40.06 %)
EPS:	KRW-30.19

Financial Reports:

No articles found.

EuBiologics Co., Ltd.

EuBiologics Co., Ltd., a biopharmaceutical company, develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine. The company also provides customized services for mammalian cell and microbial cell derived biopharmaceuticals in accordance with the clients' project stages, including cell line development, GMP production, validation, and the regulatory support; and operates facilities that manufacture protein-based therapeutics and antibodies. It specializes in manufacturing a range of mammalian cell and microbial cell derived biopharmaceuticals, including recombinant biological products and antibody therapeutics. In addition, the company offers process, formulation, and analytical method development, as well as licensing consulting services; and contract testing services that include lot release, stability, raw material, and method validation testing services. The company was founded in 2010 and is based in Seoul, South Korea.